GSA Capital Partners LLP acquired a new stake in Nutanix, Inc. (NASDAQ:NTNX - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 16,900 shares of the technology company's stock, valued at approximately $1,001,000.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of Nutanix during the second quarter valued at $25,000. ORG Wealth Partners LLC bought a new position in shares of Nutanix during the third quarter valued at $27,000. Itau Unibanco Holding S.A. bought a new position in shares of Nutanix during the second quarter valued at $32,000. GAMMA Investing LLC raised its stake in Nutanix by 35.2% during the second quarter. GAMMA Investing LLC now owns 933 shares of the technology company's stock worth $53,000 after buying an additional 243 shares during the last quarter. Finally, Signaturefd LLC raised its stake in Nutanix by 57.8% during the third quarter. Signaturefd LLC now owns 956 shares of the technology company's stock worth $57,000 after buying an additional 350 shares during the last quarter. Institutional investors own 85.25% of the company's stock.
Insider Buying and Selling
In other Nutanix news, COO David Sangster sold 11,950 shares of Nutanix stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $59.83, for a total value of $714,968.50. Following the sale, the chief operating officer now owns 123,868 shares of the company's stock, valued at approximately $7,411,022.44. The trade was a 8.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Rukmini Sivaraman sold 24,316 shares of Nutanix stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $58.85, for a total transaction of $1,430,996.60. Following the completion of the sale, the chief financial officer now directly owns 192,169 shares in the company, valued at approximately $11,309,145.65. This represents a 11.23 % decrease in their position. The disclosure for this sale can be found here. 6.80% of the stock is owned by corporate insiders.
Nutanix Price Performance
Shares of NASDAQ NTNX traded down $1.56 during mid-day trading on Friday, reaching $69.53. 1,779,402 shares of the company's stock traded hands, compared to its average volume of 2,487,332. The stock has a market cap of $18.44 billion, a P/E ratio of -133.71, a PEG ratio of 14.53 and a beta of 1.17. The business has a 50-day simple moving average of $62.90 and a 200 day simple moving average of $59.10. Nutanix, Inc. has a 1-year low of $38.60 and a 1-year high of $73.69.
Nutanix (NASDAQ:NTNX - Get Free Report) last released its quarterly earnings results on Wednesday, August 28th. The technology company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.02. Nutanix had a negative net margin of 5.81% and a negative return on equity of 7.57%. The business had revenue of $547.95 million for the quarter, compared to analysts' expectations of $537.12 million. Equities research analysts anticipate that Nutanix, Inc. will post 0.27 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the stock. JPMorgan Chase & Co. lifted their target price on shares of Nutanix from $65.00 to $75.00 and gave the stock an "overweight" rating in a research note on Thursday, August 29th. Northland Securities lifted their target price on shares of Nutanix from $71.00 to $74.00 and gave the stock a "market perform" rating in a research note on Friday, August 30th. Royal Bank of Canada lifted their target price on shares of Nutanix from $70.00 to $75.00 and gave the stock an "outperform" rating in a research note on Thursday, August 29th. Morgan Stanley raised shares of Nutanix from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $71.00 to $72.00 in a research note on Monday, October 28th. Finally, Barclays raised their price target on shares of Nutanix from $71.00 to $75.00 and gave the stock an "overweight" rating in a report on Thursday, August 29th. Three research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $73.86.
Get Our Latest Stock Analysis on NTNX
Nutanix Profile
(
Free Report)
Nutanix, Inc provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa. The company offers hyperconverged infrastructure software stack that converges virtualization, storage, and networking services into a turnkey solution; Acropolis Hypervisor, an enterprise-grade virtualization solution; flow virtual networking and flow network security, which offers services to visualize the network, automate common network operations, and build virtual private networks; Nutanix Kubernetes Engine for automated deployment and management of Kubernetes clusters to simplify the provisioning, operations, and lifecycle management of cloud-native environments, applications, and microservices; and Nutanix Cloud Clusters.
Read More
Before you consider Nutanix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutanix wasn't on the list.
While Nutanix currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.